ArticleFrontiers in public health2026
Pathogen prevalence, feature composition and cross-centre generalisability of machine learning diagnostic models for multi-pathogen respiratory infection.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the predictive information contained in the restricted surveillance feature set (demographic, temporal and specimen variables) for respiratory pathogen identification, and to examine factors associated with model performance. Methods: We retrospectively analysed 24,689 acute respiratory infection cases from seven sentinel hospitals in Sichuan, China; after quality control, 21,395 samples with complete 21-pathogen testing were included. Per-pathogen multi-label binary classifiers were trained using 15 features available at presentation; logistic regression, random forest, back-propagation neural network and XGBoost were compared under an identical split and threshold-selection protocol, with thresholds derived from out-of-fold probabilities. Label-definition sensitivity, leave-one-hospital-out cross-validation and prevalence-performance association were analysed. Results: Random forest and XGBoost performed comparably (XGBoost the primary model), with Macro-F1 0.1553 (95% CI 0.104-0.2091), 0.2202 for common pathogens and Macro-AUC 0.7702; the four-algorithm spread was 0.0611. Log-prevalence correlated strongly with per-pathogen F1 ( Conclusion: Models built on the restricted surveillance feature set showed limited diagnostic performance and were not demonstrated suitable for clinical deployment. Performance was strongly associated with pathogen prevalence and constrained by limited feature informativeness, while algorithm choice contributed little and cross-centre generalisability was limited. Priorities include multimodal feature integration, rare-pathogen accrual and prospective multicentre external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.